Treatment of pediatric influenza with OSV or ZNV for 5 days significantly suppressed acquired anti-IAV S-IgA levels in nasal washes (Table 2) and these changes may also explain the higher frequency of re-infection in the OSV and ZNV groups in the subsequent year (Figure 1). The gene discussed is CD79A; the disease is influenza.